BRIEF-Seair announces default on senior debt
* Seair Inc - defaulted on terms of its senior debt senior debt and is currently in negotiations with its creditors to develop a restructuring plan
Nov 30 Cytokinetics Inc
* Says Amgen and co announced Lancet published results from a Phase 2 clinical trial evaluating omecamtiv mecarbil
* Cytokinetics - statistically significant improvements in all pre-specified secondary measures
* Cytokinetics Inc says Adverse Events (AES), including serious AES, in patients on omecamtiv mecarbil were comparable to placebo Source text for Eikon: Further company coverage:
* Sets regular quarterly dividend of $0.2425 per share Source text for Eikon: Further company coverage:
Feb 24 Citigroup Inc on Friday said that U.S. government and regulatory agencies are investigating the bank's hiring practices.